Influenza vaccine effectiveness in the United States during 2012-2013: Variable protection by age and virus type

Journal of Infectious Diseases

Volumn 211, Issue 10, 2015, Pages 1529-1540

  McLean, Huong Q ^a   Thompson, Mark G ^b   Sundaram, Maria E ^a   Kieke, Burney A ^a   Gaglani, Manjusha ^c   Murthy, Kempapura ^c   Piedra, Pedro A ^d   Zimmerman, Richard K ^e   Nowalk, Mary Patricia ^e   Raviotta, Jonathan M ^e   Jackson, Michael L ^f   Jackson, Lisa ^f   Ohmit, Suzanne E ^g   Petrie, Joshua G ^g   Monto, Arnold S ^g   Meece, Jennifer K ^a   Thaker, Swathi N ^b   Clippard, Jessie R ^b   Spencer, Sarah M ^b   Fry, Alicia M ^b   Belongia, Edward A ^a   more..

^a MARSHFIELD CLINIC   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f CENTER FOR HEALTH STUDIES   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Influenza; Medically attended influenza; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DISEASE DURATION; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA B VIRUS (B VICTORIA); INFLUENZA B VIRUS (B YAMAGATA); INFLUENZA VACCINATION; INFLUENZA VIRUS B; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOSE SMEAR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; THROAT CULTURE; TREND STUDY; UNITED STATES; YOUNG ADULT; AGE; CROSS PROTECTION; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE; PRESCHOOL CHILD; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS PROTECTION; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84929434090     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu647     Document Type: Article

References (31)

1. Belongia EA, Kieke BA, Donahue JG, et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67.
2. Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine 2011; 29:6558-63.
3. Treanor JJ, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
4. Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
5. Centers for Disease Control and Prevention. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2013. MMWR Morb Mortal Wkly Rep 2013; 62:32-5.
6. Centers for Disease Control and Prevention. Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119-23.
7. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza Vaccine Effectiveness in the Community and the Household. Clin Infect Dis 2013; 56:1363-9.
8. Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: A population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014; 58:449-57.
9. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012; 55:332-42.
10. Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis 2013; 57:474-6.
11. Skowronski DM, Janjua NZ, Sabaiduc S, et al. Influenza A/Subtype and B/Lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis 2014; 210:126-37.
12. Skowronski DM, Janjua NZ, De Serres G, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014; 9:e92153.
13. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59 (RR-8):1-62.
14. Centers for Disease Control and Prevention. Update: influenza activity-United States and worldwide, May 19-September 28, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:838-42.
15. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8.
16. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9.
17. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013; 18:pii:20585.
18. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR Recomm Rep 2012; 61:613-8.
19. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. 2012. http://www.who.int/influenza/vaccines/virus/recommendations/201202-recommendation.pdf. Accessed 15 December 2014.
20. Andrews N, Waight P, Yung CF, Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011; 203:32-9.
21. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring healthrelated quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36:551-9.
22. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8.
23. Skowronski D, Janjua N, De Serres G, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada s sentinel surveillance network, January 2013. Euro Surveill 2013; 18:pii:20394.
24. Valenciano M, Kissling E. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13. Euro Surveill 2013; 18:pii:20400.
25. Kissling E, Valenciano M, Buchholz U, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014; 19:pii:20701.
26. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013.MMWRRecomm Rep 2013; 62:356.
27. Bragstad K, Emborg H, Kolsen Fischer T, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13-a rapid epidemiological and virological assessment. Euro Surveill 2013; 18:pii:20397.
28. Lambert ND, Ovsyannikova IG, Pankratz VS, Jacobson RM, Poland GA. Understanding the immune response to seasonal influenza vaccination in older adults: A systems biology approach. Exp Rev Vaccines 2012; 11:985-94.
29. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
30. Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: A metaanalysis of serologic and field studies. Arch Internal Med 1999; 159:182-8.
31. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA 1999; 96:14001-6.